Chief Operating Officer · Cardiff Oncology, Inc. · Cardiff Oncology, Inc. — Stock Options
Side
A
Value
—
Shares
400.0K
Price
—
Executed
Apr 27, 2026
Disclosed
Apr 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 27 executedApr 28, 2026 disclosed
CRDF · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Aggarwal Ajay filed this Form 4 reporting a grant or award of CRDF on Apr 27, 2026. It became public on Apr 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Operating Officer
Aggarwal Ajaycik:0002132312
Issuer
Cardiff Oncology, Inc.cik:0001213037
Revision history · 0
No field has changed since this record was first ingested.
